The toll receptor TLR9 may also play some role as administration of the ligand CpG (which acts through TLR9) reduced infections in neonatal mice by 95% and increased IL-12 and IFN-γ compared to controls (Barrier et al., 2006). The gene discussed is IFNG; the disease is infection.